Skip to content

A Multicenter Retrospective Study of Endoscopic Resection for Superficial Cancer at the Hypopharyngeal Esophageal Transition Zone

A Multicenter Retrospective Study of Endoscopic Resection for Superficial Cancer at the Hypopharyngeal Esophageal Transition Zone - HETZ Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060996
Enrollment
100
Registered
2026-04-01
Start date
2025-08-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypopharyngeal cancer, Esophageal cancer

Interventions

None listed

Sponsors

Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with superficial cancer of the cervical esophagus or the hypopharynx extending into hypopharynegal esophageal transition zone who underwent endoscopic resection. 2. Histopathologically diagnosed squamous cell carcinoma, including high-grade intraepithelial neoplasia and severe dysplasia. 3. Negative deep resection margin in the resected specimen. 4. No clinical evidence of lymph node metastasis. 5. Availability of intraoperative endoscopic images. 6. Availability of formalin-fixed, paraffin-embedded (FFPE) tissue sections of the tumor obtained at the time of endoscopic resection.

Exclusion criteria

Exclusion criteria: 1. Presence of unresectable multiple primary cancers in the head and neck or esophageal region at the time of endoscopic resection. 2. Presence of unresectable synchronous primary cancer in other organs at the time of endoscopic resection. 3. Cases with extremely short follow-up periods or an excessive amount of missing data, making reliable analysis difficult.

Design outcomes

Primary

MeasureTime frame
Overall survival, recurrence-free survival, disease-free survival, and disease-specific survival

Secondary

MeasureTime frame
The associations of patient characteristics, disease stage, lesion-related factors, early treatment-related adverse events, post-treatment stricture, and the occurrence of metachronous multiple and synchronous cancers with survival outcomes and adverse event rates will be examined.

Countries

Japan

Contacts

Public ContactYo Kishimoto

Graduate School of Medicine, Kyoto University Department of Otolaryngology-Head and Neck Surgery

y_kishimoto@ent.kuhp.kyoto-u.ac.jp+81-75-751-3346

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026